MAIN


1996-2018. All Rights Reserved. Online Journal of Veterinary Research . You may not store these pages in any form except for your own personal use. All other usage or distribution is illegal under international copyright treaties. Permission to use any of these pages in any other way besides the  before mentioned must be gained in writing from the publisher. This article is exclusively copyrighted in its entirety to OJVR.This article may be copied once but may not be, reproduced or  re-transmitted without the express permission of the editors. This journal satisfies the refereeing requirements (DEST) for the Higher Education Research Data Collection (Australia). Linking: :To link to this page or any pages linking to this page you must link directly to this page only here rather than put up your own page.


 OJVRTM

Online Journal of Veterinary Research 

15 (3): 283-290, 2011. Redacted 2017.


Effect of intranasal live gdhA derivative P. multocida B:2 vaccine on herd immunity in buffaloes.

 

Rafidah O1,2, Zamri-Saad M1, Nasip E2, Saharee AA1

 

1Faculty of Veterinary Medicine, Universiti Putra Malaysia, and 2Department of Veterinary Services and Animal Industry, Kota Kinabalu, Sabah, Malaysia

 

Abstract

 

Rafidah O, Zamri-Saad M, Nasip E, Saharee AA., Effect of intranasal live gdhA derivative P. multocida B:2 vaccine on herd immunity in buffaloes. Onl J Vet Res., 15 (3): 283-290, 2011. Effects of a live attenuated gdhA derivative P. multocida B:2 vaccine on immunity in buffalo herds are described. Three groups of 30 to 50 buffaloes selected from a haemorrhagic septicaemia-endemic and non-endemic area were used. Thirty percent of animals in each group were given intranasal 5 ml inoculum 106 cfu/mL live attenuated gdhA derivative P. multocida B:2. After exposure, vaccinated buffaloes were mingled with non-vaccinated animals of the same group. A booster dose was given 10 months after the first exposure. Serum samples were randomly collected from 30% of each group before vaccination and at 2-month intervals for 22 months to determine herd immune status by ELISA. Endemic or non-endemic herd status was compared with 15 non-vaccinated controls. Results revealed high herd antibody levels in endemic and non-endemic areas before vaccination. After vaccination, herd antibody levels in both areas gradually increased to peak values by the 6th month and then started to gradually decline until month 10. Following booster dose at 10th month, antibodies declined to levels similar to those in unvaccinated animal at 12 to 14 months. Antibody levels then recovered at 22-months (end of study). It was concluded that field vaccination using gdhA derivative P. multocida B:2 increased herd immunity for 8 to 10 months before a booster dose was required.

 

Key words: gdhA derivative Pasteurella multocida B:2; immune response; field buffalo


MAIN

 

FULL-TEXT (SUBSCRIPTION OR PURCHASE TITLE $25USD)